dallas semaglutide ileus attorney in FDA Investigation Defense semaglutide law office in – dallas semaglutide gi obstruction legal

October 2025 The month of October started off with 2,809 lawsuits pending in the GLP-1RA MDL, according to JPML reports

The second indication is chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity such as hypertension, dyslipidemia, or obstructive sleep apnea

For most patients, the constipation is worst during the first 3 months of treatment or during dosage increases (e.g., moving from 5mg to 7.5mg )

The methods comprise the step of administering to said patient an amount of one or more hepatocyte growth factor mimics sufficient to prevent, improve and/or restore to normal said cognitive function

One of its main roles is to promote the production of telomerase